A Challenging Task: Identifying Patients with Cancer of Unknown Primary (CUP) According to ESMO Guidelines: The CUPISCO Trial Experience

Author
Mueller-Ohldach, Mathis
Kramer, Alwin
Scarato, Jeremy
Thomas, Marlene
Moch, Holger
Pauli, Chantal
Bochtler, Tilmann
Mileshkin, Linda
Baciarello, Giulia
Losa, Ferran
Ross, Jeffrey S.
Pentheroudakis, George
Zarkavelis, George
YALÇIN, ŞUAYİB
ÖZGÜROĞLU, Mustafa
Beringer, Andreas
Metadata
Show full item record
Abstract
Background CUPISCO is an ongoing randomized phase II trial (NCT03498521) comparing molecularly guided therapy versus platinum-based chemotherapy in patients newly diagnosed with "unfavorable" cancer of unknown primary (CUP).
URI
http://hdl.handle.net/20.500.12627/168139
https://doi.org/10.1002/onco.13744
Collections